MMP9 and prostate cancer: Small molecule Mmp9 inhibitors are currently in clinical trials for Multiple Sclerosis, Chronic Obstructive Pulmonary Disease and Prostate Cancer [38], [48], and may aid the pursuit of Mmp9 inhibition during tendon healing.